Website KingsCollegeLon King's College London
Closing date: 12th December
King’s College London has recieved funding from Alzheimer’s Research UK to hire a Research Associate to investigate ER-mitochondria Signaling as a Therapeutic Target for Dementia.
Applications are invited for a postdoctoral research associate to be based in the Department of Basic and Clinical Neuroscience at King’s College London. The post is funded by the Alzheimer’s Research UK for at least 18 months and will investigate the role of defective endoplasmic reticulum (ER)-mitochondria signaling in dementia and amyotrophic lateral sclerosis (ALS). ER-mitochondria signaling and its role in dementia/ALS are highly topical areas of research and the grant holders have made major contributions to these fields.
The successful applicant will join a multi-disciplinary group that seeks to understand the mechanisms by which ER-mitochondria signaling is perturbed in dementia/ALS and how correcting damaged ER-mitochondria signaling might be therapeutic for these major diseases.
The post will focus on how the Sigma-1 receptor affects ER-mitochondria tethering and signaling, and how novel compounds that target ER-mitochondria tethering proteins might in have therapeutic potential for dementia and ALS. Experience in cell and molecular biology approaches including advanced light microscopy and experimental manipulation of neurons would be advantageous. Knowledge of defective signaling processes in dementia and related disorders will also be useful. You will join an established research group and will have access to state-of-the-art facilities in both King’s College and the King’s College Dementia Research Institute. For further information on our work see https://kclpure.kcl.ac.uk/en/persons/christopher-miller
This post will be offered on a full-time, fixed term contract for 18 months.
- To use cell, molecular and advanced microscopy approaches to understand the roles that the Sigma-1 receptor has on ER-mitochondria tethering proteins and signaling functions, and to probe the therapeutic benefits of Sigma-1 receptor agonists in cell models of dementia and ALS.
- To use cell, molecular and advanced microscopy approaches to understand the roles that novel small molecules that we have identified have on ER-mitochondria tethering proteins and signaling functions, and to probe the therapeutic benefits of these molecules in cell models of dementia and ALS.
- To conduct literature reviews and contribute to publications arising from this project.
- Attend and as appropriate, present research findings and papers at internal and external academic meetings and external professional conferences, and to contribute to the internal and external visibility of the departments and group.
The above list of responsibilities may not be exhaustive, and the post holder will be required to undertake such tasks and responsibilities as may reasonably be expected within the scope and grading of the post.
To apply for this job please visit www.kcl.ac.uk.